Form 4: Tyra Biosciences CFO Buys Shares via ESPP

Tyra Biosciences' Chief Financial Officer, Alan Fuhrman, acquired 701 shares of common stock at $9.129 per share through the company's Employee Stock Purchase Plan.

Summary

• Alan Fuhrman, Chief Financial Officer of Tyra Biosciences, Inc. (TYRA), acquired 701 shares of common stock.
• The transaction occurred on September 15, 2025, at a price of $9.129 per share.
• These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
• Following this transaction, Alan Fuhrman directly beneficially owns 14,788 shares of common stock.

Sentiment

Score: 6

Explanation: A score of 6 reflects a slightly positive sentiment due to an insider acquiring shares, which generally indicates confidence. However, as it's an ESPP purchase, it's a routine transaction and not a strong signal of discretionary open-market buying.

Positives

• Insider acquisition of shares, even through an Employee Stock Purchase Plan (ESPP), can signal management's confidence in the company's future prospects.
• Participation in the ESPP aligns management's interests with those of shareholders.

Negatives

• No negative information is disclosed in this routine insider transaction filing.

Risks

• This Form 4 filing does not contain information regarding company-specific risks.

Future Outlook

This filing does not provide any forward-looking statements or guidance.

Industry Context

This routine insider transaction does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual executive's participation in an employee benefit plan.

Related Party Transactions

• This filing details an acquisition of shares by an officer through an Employee Stock Purchase Plan, which is a standard employee benefit.

Stakeholder Impact

• Shareholders may view the CFO's share acquisition as a minor positive signal of management confidence and alignment of interests.
• Employees may note the transaction as an example of participation in the Employee Stock Purchase Plan.

Key Dates

Keywords

Tyra Biosciences, TYRA, Alan Fuhrman, CFO, Insider Trading, Form 4, Stock Purchase, ESPP, Common Stock, Biotechnology